Weekly 5-fluorouracil and leucovorin: Achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection

被引：0
|
作者：
Waterhouse, C
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2005年 / 181卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：58 / 60
页数：3
相关论文
共 50 条
  • [1] Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection
    Patel, K
    Anthoney, DA
    Crellin, AM
    Sebag-Montefiore, D
    Messruther, J
    Seymour, AT
    ANNALS OF ONCOLOGY, 2004, 15 (04) : 568 - 573
  • [2] A Pilot study of adjuvant hepatic arterial infusion chemotherapy, associating 5-fluorouracil and leucovorin, after resection of colorectal cancer liver metastases
    Porte, H
    DeMoulins, H
    Gambiez, L
    Wurtz, A
    Quandalle, P
    SURGICAL ONCOLOGY-OXFORD, 1995, 4 (06): : 317 - 322
  • [3] Adjuvant chemotherapy with 5-fluorouracil and folinic acid in colorectal cancer: Evaluation of toxicity
    Hartung, G
    Queisser, W
    Diezler, P
    Hagmuller, E
    Edler, L
    Jacob, I
    Wojatschek, C
    Seifert, A
    Weiss, H
    Weh, HJ
    Hoffknecht, M
    Clemens, MR
    Fritze, D
    Katz, R
    Harle, M
    ONKOLOGIE, 1996, 19 (01): : 62 - 67
  • [4] Potent effects of adjuvant chemotherapy using 5-fluorouracil + leucovorin on DNA aneuploid colorectal cancer
    Yamamoto T.
    Matsumoto K.
    Iriyama K.
    International Journal of Clinical Oncology, 1998, 3 (3) : 165 - 170
  • [5] Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
    Nicolas Tsavaris
    Christos Kosmas
    Maria Vadiaka
    Christos Koufos
    BMC Cancer, 2
  • [6] Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
    Tsavaris, N
    Kosmas, C
    Vadiaka, M
    Koufos, C
    BMC CANCER, 2002, 2 (1)
  • [7] Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer
    Focan, C
    Bury, J
    Beauduin, M
    Herman, ML
    Vindevoghel, A
    Lecomte, M
    Brohée, D
    Canon, JL
    Focan-Henrard, D
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4665 - 4672
  • [8] Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin
    Dencausse, Y
    Hartung, G
    Sturm, J
    Kopp-Schneider, A
    Hagmüller, E
    Wojatschek, C
    Lindemann, H
    Fritze, D
    Queisser, W
    ONKOLOGIE, 2002, 25 (05): : 426 - 430
  • [9] Dose intensity of oxaliplatin in 5-fluorouracil and leucovorin regimens in pretreated metastatic colorectal cancer.
    Jeong, KJ
    Oh, JM
    Choi, SK
    Oh, D
    PHARMACOTHERAPY, 2002, 22 (10): : 1356 - 1356
  • [10] Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer
    Ahn, JB
    Shim, KY
    Jeung, HC
    Rha, SY
    Yoo, NC
    Kim, NK
    Roh, JK
    Min, JS
    Kim, BS
    Chung, HC
    CANCER LETTERS, 2001, 167 (02) : 215 - 224
12345